Andrew Sheldon
Chairman
Immuno-oncology
Immunovaccine Inc.
Canada
Biography
Andy has 30 years of experience in the pharmaceutical industry, and was named CEO of the Year in the World Vaccine Congress’s Vaccine Industry Excellence Awards in April 2012. He spent a significant portion of his career at Medicago, serving as its President and CEO since 2003. Before joining Medicago, he served as Vice President, Sales and Marketing, of Shire Biologics. He was responsible for international expansion with European, American and Asian private partnership agreements. During his tenure at Shire, Andy’s notable accomplishments included negotiating the annual and pandemic influenza vaccine contract with federal and provincial governments, and managing the approval of a bladder cancer therapeutic vaccine by the US Food and Drug Administration. Andy has a Bachelor’s degree in agricultural sciences from Université Laval, Québec City, and a BS degree with honors in Biological Sciences from the University of East Anglia, in Norwich, England.
Research Interest
Biological Sciences
